Martha Gulati/www.womenheart.org; Annalisa Filtz, Leandro Slipczuk/LinkedIn
Mar 21, 2026, 11:34
Martha Gulati: How Does Lp(a) Drive Atherosclerosis?
Martha Gulati, Director of the Davis Women Heart Center at Houston Methodist DeBakey Heart and Vascular Center, shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“How does Lp(a) drive atherosclerosis?
- Delivers cholesterol to the arterial wall
- Carries oxidized phospholipids, leading to vascular inflammation
- Interferes with plasminogen, resulting in impaired fibrinolysis
- Promotes an atherothrombotic environment
Understanding these mechanisms strengthens the case for targeted Lp(a) therapies.”
Title: Presumed Mechanisms Underlying Lipoprotein(a)-caused Atherosclerosis
Authors: Annalisa Filtz, Leandro Slipczuk, Martha Gulati
Read the Full Article on ECR Journal.
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 9, 2026, 13:48PF4-ELISA–Negative HIT: Are We Missing a New Class of Anti-PF4 Immunothrombotic Disease?
-
Nov 9, 2026, 13:07Nandini Sadasivam: Gene Therapy for Sickle Cell Disease and Thalassaemia
-
Nov 9, 2026, 13:04Raising Awareness of Bleeding Disorders in Women and Girls – EHC
-
Nov 9, 2026, 12:59Rahul Bohra: Exploring the Complex Mechanisms of Sickle Cell Disease
-
Nov 9, 2026, 12:53Three Years of Movement and Thrombosis Awareness in the Czech Republic – World Thrombosis day
-
Nov 9, 2026, 12:51Octavio Marques Pontes-Neto: Intensive Blood-Pressure Control Reduces Cardiovascular Events After Ischemic Stroke
-
Nov 9, 2026, 12:49Irma Bagdoniene: What Really Makes Us Live Longer
-
Nov 9, 2026, 12:47Imo Akpan: Announcing the 2027 Women’s Hematology Summit
-
Nov 9, 2026, 12:45Shadi Yaghi: Rethinking Antithrombotic Therapy After Stroke